Erratum to: “Cutaneous T‐Cell Lymphomas: 2023 Update on Diagnosis, Risk‐Stratification, and Management”
Year: 2025
Type: erratum
Abstract: A. C. Hristov, T. Tejasvi, R. A. Wilcox, and T. Cutaneous, “Cutaneous T-Cell Lymphomas: 2023 Update on Diagnosis, Risk-Stratification, and Management,” American Journal of Hematology 98, no. 1 (2023 Jan): 193–209, https://doi.org/10.1002/ajh.26760. In the manuscript, on Page 196, Lines 33–37, it is remarked that “recent consensus recommendations support of the use of peripheral blood flow cytometry in specific patient groups: those with advanced stage (≥ IIB) disease, intractable pruritis, generalize patches/plaques, erythroderma, lymphocytosis, an elevated LDH, or a lack of response to skin-directed therapies.” However, upon review of the primary research (Citation 81) this line references, it appears this statement is misleading. In the article referenced, Vermeer MH, Moins-Teisserenc H, Bagot M, Quaglino P, Whittaker S. Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach. Br J Dermatol. 2022 Jul;187(1):21-28. doi: https://doi.org/10.1111/bjd.21053. Epub 2022 May 3. PMID: 35157307; PMCID: PMC9541328., the populations listed on Page 24, Table 2 are listed for “for minimum use of flow cytometry for mycosis fungoides and Sézary syndrome when not performed at all stages” meaning if it is not practical to perform flow cytometry on all patients, these populations at a minimum need to have the testing performed. In your review article as it is currently written, it implies that those are the only groups that flow cytometry should be performed in. This is an important distinction as some patients with a clinically perceived limited stage disease can in fact have a large blood burden making the use of flow cytometry if possible important in all patients as it has significant implications on prognosis and treatment.
Source: American Journal of Hematology
DOI: 10.1002/ajh.70135
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415880496
Cites:
Cited by:
Related to:
